Overview
Background
I oversee the production and quality assurance of bioactive heparan sulfates (HS) used across various collaborative projects. In this role, I specialise in the selection and evaluation of pro-angiogenic HS through in vitro testing, their integration into biomaterials, and their subsequent assessment in preclinical animal models. My expertise encompasses a diverse range of skills, including biomaterial substrate fabrication (hydrogels, sponges, nano/micropatterned surfaces), structural and compositional characterisation, drug delivery systems, tissue processing (cell isolation, decellularisation, anastomosis), and cell-material interface analysis with a focus on signalling pathways (mechanotransduction and topographical cues). Collectively, I have contributed to multiple translational tissue engineering projects aimed at advancing regenerative medicine strategies for cardiovascular, dermal, bone and neural tissues. These multidisciplinary initiatives required close collaboration with program managers, scientists, and clinicians to ensure rigorous, high-quality research—from the in vitro characterisation of cellularised biomaterials to their successful implementation for in vivo studies.
Availability
- Dr Nicolas Alexis Marinval is:
- Available for supervision
Qualifications
- Doctor of Philosophy of Cell Biology, University Sorbonne Paris Cite - Paris XIII
Research impacts
-
Enabling safer, more effective biomaterials: Pioneered approaches to integrate growth factor–binding sugars into scaffolds and implants, creating “smart” materials that control healing responses. These advances bring regenerative medicine closer to real-world clinical solutions.
-
Next-generation vascular grafts: Engineered small-diameter artificial blood vessels with improved surface properties that encourage natural healing and reduce clotting risk. These innovations address a major unmet need in bypass surgery, where current synthetic grafts often fail.
-
Advancing breast cancer reconstruction options: Developed strategies to improve the survival and integration of fat grafts used in breast reconstruction. By enhancing blood vessel growth with bioactive sugars (heparan sulfates), this work supports safer, more durable outcomes for patients undergoing reconstructive surgery.
-
Accelerating bone repair: Contributed to the design of a bioresorbable scaffold combining advanced polymers, minerals, and bioactive molecules to promote bone regeneration. This technology provides a foundation for safer, faster recovery from complex bone injuries, particularly in oral and maxillofacial surgery.
-
Improving durability of heart valve implants: Developed a surface-modification technique for animal-derived heart valves that reduces blood clotting and supports tissue regeneration. This innovation may extend the life of bioprosthetic valves and reduce the need for repeat surgeries.
-
Insights into brain repair and drug discovery: Demonstrated how changes in tissue stiffness affect the ability of brain cells to form protective myelin, providing new tools for studying neurological diseases and screening potential therapies. Additionally, advanced microgel systems for gene delivery were tested for spinal cord injury applications, offering a platform for future regenerative treatments.
Overall impact: My research contributes to the development of innovative biomaterials and regenerative therapies that improve healing outcomes in cardiovascular, bone, neural, and reconstructive medicine. By collaborating with clinicians and industry partners, these projects lay the groundwork for medical technologies that enhance patient recovery, reduce complications, and lower healthcare costs.
Works
Search Professor Nicolas Alexis Marinval’s works on UQ eSpace
2023
Conference Publication
Artificial small-diameter blood vessel with enhanced endothelialisation properties
Marinval, Nicolas, Tang, Xuan Hao, Brackovic, Amira, Sugiarto, Sigit, Meroshini, M., Kai, Dan, Beh, Cyrus, Dunn, Ray and Cool, Simon (2023). Artificial small-diameter blood vessel with enhanced endothelialisation properties. European Chapter of the Tissue-Engineering-and-Regenerative-Medicine-International-Society (TERMIS), Manchester, United Kingdom, 28-31 March 2023. New Rochelle, NY United States: MARY ANN LIEBERT.
2021
Journal Article
Mechanotransduction assays for neural regeneration strategies: a focus on glial cells
Marinval, Nicolas and Chew, Sing Yian (2021). Mechanotransduction assays for neural regeneration strategies: a focus on glial cells. APL Bioengineering, 5 (2) 021505, 1-29. doi: 10.1063/5.0037814
2020
Journal Article
PDMMLA derivatives as a promising cardiovascular metallic stent coating: physicochemical and biological evaluation
Belibel, R., Sali, S., Marinval, N., Garcia-Sanchez, A., Barbaud, C. and Hlawaty, H. (2020). PDMMLA derivatives as a promising cardiovascular metallic stent coating: physicochemical and biological evaluation. Materials Science and Engineering: C, 117 111284, 1-12. doi: 10.1016/j.msec.2020.111284
2020
Journal Article
Biomimicking fiber platform with tunable stiffness to study mechanotransduction reveals stiffness enhances oligodendrocyte differentiation but impedes myelination through YAP‐dependent regulation
Ong, William, Marinval, Nicolas, Lin, Junquan, Nai, Mui Hoon, Chong, Yee‐Song, Pinese, Coline, Sajikumar, Sreedharan, Lim, Chwee Teck, Ffrench‐Constant, Charles, Bechler, Marie E. and Chew, Sing Yian (2020). Biomimicking fiber platform with tunable stiffness to study mechanotransduction reveals stiffness enhances oligodendrocyte differentiation but impedes myelination through YAP‐dependent regulation. Small, 16 (37) 2003656, 1-13. doi: 10.1002/smll.202003656
2018
Journal Article
Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses
Marinval, N., Morenc, M., Labour, M.N., Samotus, A., Mzyk, A., Ollivier, V., Maire, M., Jesse, K., Bassand, K., Niemiec-Cyganek, A., Haddad, O., Jacob, M.P., Chaubet, F., Charnaux, N., Wilczek, P. and Hlawaty, H. (2018). Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses. Biomaterials, 172, 14-29. doi: 10.1016/j.biomaterials.2018.01.054
2016
Journal Article
Identification of a pro-angiogenic potential and cellular uptake mechanism of a LMW highly sulfated fraction of fucoidan from Ascophyllum nodosum
Marinval, Nicolas, Saboural, Pierre, Haddad, Oualid, Maire, Murielle, Bassand, Kevin, Geinguenaud, Frederic, Djaker, Nadia, Ben Akrout, Khadija, Lamy de la Chapelle, Marc, Robert, Romain, Oudar, Olivier, Guyot, Erwan, Laguillier-Morizot, Christelle, Sutton, Angela, Chauvierre, Cedric, Chaubet, Frederic, Charnaux, Nathalie and Hlawaty, Hanna (2016). Identification of a pro-angiogenic potential and cellular uptake mechanism of a LMW highly sulfated fraction of fucoidan from Ascophyllum nodosum. Marine Drugs, 14 (10) 185, 185. doi: 10.3390/md14100185
2016
Journal Article
Poly((R,S)-3,3-dimethylmalic acid) derivatives as a promising cardiovascular metallic stent coating: Biodegradation and biocompatibility of the hydrolysis products in human endothelial cells
Belibel, R., Marinval, N., Hlawaty, H. and Barbaud, C. (2016). Poly((R,S)-3,3-dimethylmalic acid) derivatives as a promising cardiovascular metallic stent coating: Biodegradation and biocompatibility of the hydrolysis products in human endothelial cells. Polymer Degradation and Stability, 130, 288-299. doi: 10.1016/j.polymdegradstab.2016.06.008
2015
Journal Article
Heparanase and syndecan-4 are involved in low molecular weight fucoidan-induced angiogenesis
Haddad, Oualid, Guyot, Erwan, Marinval, Nicolas, Chevalier, Fabien, Maillard, Loïc, Gadi, Latifa, Laguillier-Morizot, Christelle, Oudar, Olivier, Sutton, Angela, Charnaux, Nathalie and Hlawaty, Hanna (2015). Heparanase and syndecan-4 are involved in low molecular weight fucoidan-induced angiogenesis. Marine Drugs, 13 (11), 6588-6608. doi: 10.3390/md13116588
2015
Journal Article
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis
Semerano, Luca, Duvallet, Emilie, Belmellat, Nadia, Marival, Nicolas, Schall, Nicolas, Monteil, Maëlle, Grouard-Vogel, Géraldine, Bernier, Emilie, Lecouvey, Marc, Hlawaty, Hanna, Muller, Sylviane, Boissier, Marie-Christophe and Assier, Eric (2015). Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis. Angiogenesis, 19 (1), 39-52. doi: 10.1007/s10456-015-9487-0
Supervision
Availability
- Dr Nicolas Alexis Marinval is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Dr Nicolas Alexis Marinval's areas of expertise, story ideas and help finding experts, contact our Media team: